Pyrrolopyrimidines and processes for their preparation
    2.
    发明授权
    Pyrrolopyrimidines and processes for their preparation 失效
    吡咯并嘧啶及其制备方法

    公开(公告)号:US6140317A

    公开(公告)日:2000-10-31

    申请号:US117056

    申请日:1998-07-22

    CPC分类号: C07D487/04

    摘要: There are described compounds of formula I ##STR1## wherein R.sub.1 and R.sub.2 are as defined in the description, Q is heterocyclyl boned via a ring nitrogen atom and having the formula IA ##STR2## wherein R.sub.3 and R.sub.4 and m and n are as defined in the description, the ring marked A is a heterocyclyl having 5 to 9 ring atoms and having at least one saturated bond, it being possible for a further ring hetero atom selected from O and S to be present in addition to the bonding nitrogen atom, the ring system marked B is a free or benzo-, thieno-, furo-, pyrrolo- or dihydropyrrolo-fused carbocyclic ring having from 5 to 9 carbon atoms that is fused to the ring A and may be unsaturated, partially saturated or fully saturated, and the bond marked by a parallel dotted line between the ring systems marked A and B is either a single bond or a double bond, and a salt thereof where at least one salt-forming group is present. The compounds are inhibitors of protein kinases and have, for example, antitumour activity.

    摘要翻译: PCT No.PCT / EP97 / 00127 Sec。 371日期:1998年7月22日 102(e)日期1998年7月22日PCT 1997年1月13日PCT PCT。 公开号WO97 / 27199 日期:1997年7月31日描述式I化合物,其中R 1和R 2如说明书中所定义,Q是经由环氮原子并具有式IA的杂环基,其中R 3和R 4以及m和n如 描述中,标记为A的环是具有5至9个环原子并且具有至少一个饱和键的杂环基,除了键合氮原子之外,还可以存在另外选自O和S的环杂原子,所述环 标记为B的系统是具有5至9个碳原子的游离或苯并,噻吩并 - 二氢吡咯并 - 稠合的碳环,其与环A稠合并且可以是不饱和的,部分饱和的或完全饱和的,以及 标记为A和B的环状体系之间的平行虚线标记的键是单键或双键,以及其中存在至少一个成盐基团的盐。 这些化合物是蛋白激酶的抑制剂,并且具有例如抗肿瘤活性。

    Pyrazole derivatives and processes for the preparation thereof
    3.
    发明授权
    Pyrazole derivatives and processes for the preparation thereof 失效
    吡唑衍生物及其制备方法

    公开(公告)号:US5981533A

    公开(公告)日:1999-11-09

    申请号:US930904

    申请日:1997-10-03

    CPC分类号: C07D487/04

    摘要: 4-Amino-1H-pyrazolo[3,4-d]pyrimidine derivatives of formula I ##STR1## wherein the symbols are as defined in claim 1, and intermediates for their manufacture are described.The compounds of formula I inhibit especially the tyrosine kinase activity of the receptor for epidermal growth factor and can be used, for example, in the case of epidermal hyperproliferation (psoriasis) and as anti-tumor agents.

    摘要翻译: PCT No.PCT / EP96 / 01263。 371日期1997年10月3日第 102(e)日期1997年10月3日PCT 1996年3月22日PCT公布。 公开号WO96 / 31510PC。 日期:19964年10月10日 - 描述了式I的氨基-1H-吡唑并[3,4-d]嘧啶衍生物,其中符号如权利要求1中所定义,其中描述其制备方法。 式I的化合物特别地抑制表皮生长因子受体的酪氨酸激酶活性,并且可以用于例如表皮过度增生(牛皮癣)和作为抗肿瘤剂的情况。

    4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
    4.
    发明授权
    4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives 失效
    4-氨基-6-苯基 - 吡咯并[2,3-d]嘧啶衍生物

    公开(公告)号:US07390805B2

    公开(公告)日:2008-06-24

    申请号:US11686023

    申请日:2007-03-14

    CPC分类号: C07D487/04

    摘要: The invention relates to 7H-pyrrolo[2,3-d]pyrimidine derivatives of formula I wherein the symbols and substituents are as defined in the description, to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivatives—alone or in combination with one or more other pharmaceutically active compounds—for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumour.

    摘要翻译: 本发明涉及式I的7H-吡咯并[2,3-d]嘧啶衍生物,其中符号和取代基如说明书中所定义,其制备方法,包含该衍生物的药物组合物及其用途 衍生物 - 单独或与一种或多种其它药学活性化合物组合 - 用于制备用于治疗特别是增殖性疾病如肿瘤的药物组合物。

    Pyrimidine derivatives and processes for the preparation thereof
    5.
    发明授权
    Pyrimidine derivatives and processes for the preparation thereof 失效
    嘧啶衍生物及其制备方法

    公开(公告)号:US06251911B1

    公开(公告)日:2001-06-26

    申请号:US09269823

    申请日:1999-04-01

    IPC分类号: C07D48704

    CPC分类号: C07D487/04

    摘要: 4-Amino-1H-pyrazolo[3,4-d]pyrimidine derivatives of formula I wherein the substituents are as defined in claim 1, are described. These compounds inhibit the tyrosine kinase activity of the receptor for epidermal growth factor (EGF) and c-erbB2 kinase and can be used as anti-tumor agents.

    摘要翻译: 描述了在取代基中如权利要求1所定义的式I的4-氨基-1H-吡唑并[3,4-d]嘧啶衍生物。这些化合物抑制表皮生长因子(EGF)和c的受体的酪氨酸激酶活性 -erbB2激酶,可用作抗肿瘤剂。

    7H-pyrrolo[2,3-d]pyrimidine derivatives
    6.
    发明授权
    7H-pyrrolo[2,3-d]pyrimidine derivatives 失效
    7H-吡咯并[2,3-d]嘧啶衍生物

    公开(公告)号:US07323469B2

    公开(公告)日:2008-01-29

    申请号:US10783000

    申请日:2004-02-20

    CPC分类号: C07D487/04

    摘要: The invention relates to 7H-pyrrolo[2,3-d]pyrimidine derivatives of formula I wherein the symbols and substituents are as defined in the description, to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivatives—alone or in combination with one or more other pharmaceutically active compounds—for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumor.

    摘要翻译: 本发明涉及式I的7H-吡咯并[2,3-d]嘧啶衍生物,其中符号和取代基如说明书中所定义,其制备方法,包含该衍生物的药物组合物及其用途 衍生物 - 单独或与一种或多种其它药学活性化合物组合 - 用于制备用于治疗特别是增殖性疾病如肿瘤的药物组合物。

    Substituted pyrrolopyrimidines and processes for their preparation
    8.
    发明授权
    Substituted pyrrolopyrimidines and processes for their preparation 失效
    取代的吡咯并嘧啶及其制备方法

    公开(公告)号:US06180636B2

    公开(公告)日:2001-01-30

    申请号:US09242592

    申请日:1999-02-19

    IPC分类号: A61K31519

    CPC分类号: C07D487/04

    摘要: There are described 7H-pyrrolo[2,3-d]pyrimidine derivatives of the formula I in which the substituents are as defined in claim 1. These compounds inhibit the tyrosine kinase activity of the receptor for the epidermal growth factor (EGF) and c-erbB2 kinase and can be used as anti-tumor agents.

    摘要翻译: 描述了式Iin的7H-吡咯并[2,3-d]嘧啶衍生物,其取代基如权利要求1中所定义。这些化合物抑制表皮生长因子(EGF)受体的酪氨酸激酶活性和c- erbB2激酶,可用作抗肿瘤剂。

    4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
    9.
    发明授权
    4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives 失效
    4-氨基-6-苯基 - 吡咯并[2,3-d]嘧啶衍生物

    公开(公告)号:US07244729B2

    公开(公告)日:2007-07-17

    申请号:US10485747

    申请日:2002-08-06

    CPC分类号: C07D487/04

    摘要: The invention relates to 7H-pyrrolo[2,3-d]pyrimidine derivatives of formula I wherein the symbols and substituents are as defined in the description, to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivatives-alone or in combination with one or more other pharmaceutically active compounds-for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumour

    摘要翻译: 本发明涉及式I的7H-吡咯并[2,3-d]嘧啶衍生物,其中符号和取代基如说明书中所定义,其制备方法,包含该衍生物的药物组合物及其用途 衍生物 - 单独或与一种或多种其它药学活性化合物组合 - 用于制备用于治疗特别是增殖性疾病如肿瘤的药物组合物

    4-AMINO-6-PHENYL-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES
    10.
    发明申请
    4-AMINO-6-PHENYL-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES 失效
    4-氨基-6-苯基 - 吡咯并[2,3-D]吡啶衍生物

    公开(公告)号:US20070161632A1

    公开(公告)日:2007-07-12

    申请号:US11686023

    申请日:2007-03-14

    CPC分类号: C07D487/04

    摘要: The invention relates to 7H-pyrrolo[2,3-d]pyrimidine derivatives of formula I wherein the symbols and substituents are as defined in the description, to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivatives—alone or in combination with one or more other pharmaceutically active compounds—for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumour.

    摘要翻译: 本发明涉及式I的7H-吡咯并[2,3-d]嘧啶衍生物,其中符号和取代基如说明书中所定义,其制备方法,包含该衍生物的药物组合物及其用途 衍生物 - 单独或与一种或多种其它药学活性化合物组合 - 用于制备用于治疗特别是增殖性疾病如肿瘤的药物组合物。